This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.

Ryzodeg® adalah insulin ko-formulasi pertama yang terdiri dari 70% Insulin degludec (Insulin basal analog pertama yang dapat dikombinasikan dengan insulin waktu makan dalam larutan tersendiri5,6), dan 30% insulin aspart (Insulin waktu makan dengan pengalaman lebih dari satu dekade4)

Ryzodeg

.cls-1 { fill: none; stroke: #001956; stroke-linecap: round; stroke-miterlimit: 10; stroke-width: 2px; }

.cls-1 { fill: none; stroke: #001956; stroke-linecap: round; stroke-miterlimit: 10; stroke-width: 2px; }

1.

Mauricio D, et al. Diabetes Obes Metab. 2017 Aug;19(8):1155-1164

2.

Peyrot et al. Diabet Med. 2012;29: 682–9

3.

Leiter et al. Can J Diabetes 2005;29:186–92

4.

Ryzodeg® Indonesia Prescribing Information. 2021

5.

Heller S, et al. Diabetes Metab Res Rev.2012;28(1):50-61

6.

Heise T, et al. Diabetes Ther. 2014;5(1):255-265

7.

Heisse et al. Diabetes Care, Volume 34, March 2011

8.

Haarh et al. Clin Pharmacokinet (2017) 56:339–354

9.

Atkin Ther Adv Chronic Dis 2015;6:375–88; 

10.

Kruszynska et al. Diabetologia 1987;30:16–21

11.

Heise et al. Diabetes Obes Metab 2012;14:859-64Heise et al. Diabetes Obes Metab 2012;14:859-64

12.

Sajay Karla. Diabetes Ther (2014) 5:65-72Sajay Karla. Diabetes Ther (2014) 5:65-72

13.

Heise et al. Expert Opin Drug Metab Toxicol 2015;11:1193–201

14.

Heise et al. Diabetes 2012;61(Suppl. 1):A259

PromoMats ID ID21RZG00039